Medicine
Miebo 1 mg/mg ophthalmic solution
Miebo 1 mg/mg ophthalmic solution is a prescription medicine containing Perfluorohexyloctane for ophthalmic use, marketed by Bausch & Lomb, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store MIEBO at 15ºC to 25ºC (59ºF to 77ºF).
Key facts
- Active ingredient (INN)
- Perfluorohexyloctane
- Brand
- Miebo
- Strength
- 1 mg/mg
- Dosage form
- Ophthalmic solution
- Route
- Ophthalmic
- Packs
- 1 bottle
- Marketing authorisation holder
- Bausch & Lomb
- Manufacturer
- Bausch & Lomb
- Origin register
- US FDA, United States
- Storage
- Store MIEBO at 15ºC to 25ºC (59ºF to 77ºF).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 May 2023
- Identifiers
- RxCUI 2637551, 2637556DailyMed set ID 6b283c02-7df4-4c00-951b-555cddffe77cNDC 24208-377Application NDA216675
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 3 mg in 1 bottle | 24208-377-05 | Bausch & Lomb | 18 May 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 May 2023 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Perfluorohexyloctane is a semifluorinated alkane indicated for the treatment of the signs and symptoms of dry eye disease (DED). It is available as ophthalmic solution. MedsAcross supplies Perfluorohexyloctane for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PerfluorohexyloctaneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- MIEBO prescribing information (Bausch & Lomb) · U.S. National Library of Medicine, DailyMed
Need Miebo 1 mg/mg ophthalmic solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.